Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease von Haider, Syedreza A., Yadav, Abhijeet, Perry, Courtney, Su, Leon, Akanbi, Olalekan, Kudaravalli, Praneeth, Tripathi, Nishant, Hashim, Mahmoud A., Abdelsalam, Mohammed, Hussein, Mohamed, Elkheshen, Ahmed, Patel, Vihang, Ali, Saad Emhmed, Lamb, Latoya, Ingram, Karen, Mayne, Casie, Stuffelbeam, Amy B., Flomenhoft, Deborah, Stromberg, Arnold, Barrett, Terrence A.

Volltext

FECAL CALPROTECTIN TESTING: AN INVESTIGATION OF PATIENT COMPLIANCE AND PERCEPTIONS von Perry, Courtney, Hashim, Mahmoud, Elmoursi, Ahmed, Elkheshen, Ahmed, Dugan, Adam, Flomenhoft, Deborah, Stuffelbeam, Amy, Barrett, Terrence

Volltext

FECAL CALPROTECTIN TESTING: AN INVESTIGATION OF PATIENT COMPLIANCE AND PERCEPTIONS von Perry, Courtney, Hashim, Mahmoud, Elmoursi, Ahmed, Elkheshen, Ahmed, Dugan, Adam, Flomenhoft, Deborah, Stuffelbeam, Amy, Barrett, Terrence

Volltext

Dual Biologic Therapy Induces Remission in Refractory Crohn’s Disease with Vedolizumab and Ustekinumab von Hassan, Syed Adeel, Perry, Courtney, Carey, Patrick, Colohan, Durham, Eltaher, Mohamed Gebril, Dawoud, Nabila, Elkammar, Mahmoud, Rasheed, Waqas, Mayne, Casie, Stuffelbeam, Amy, Flomenhoft, Deborah, Barrett, Terrence A

Volltext